Free Trial

Emergent BioSolutions (EBS) Earnings Date, Estimates & Call Transcripts

Emergent BioSolutions logo
$8.10 +0.04 (+0.50%)
(As of 12/20/2024 05:40 PM ET)
Get Emergent BioSolutions Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Emergent BioSolutions and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

EBS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EBS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Emergent BioSolutions Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241-$1.11-$1.11-$1.11 
Q2 20241$0.78$0.78$0.78 
Q3 20241$0.83$0.83$0.83 
Q4 20241$1.59$1.59$1.59 
FY 20244$2.09$2.09$2.09 
Q1 20251$0.29$0.29$0.29 
Q2 20251$1.07$1.07$1.07 

Emergent BioSolutions Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2024Q2 2024-$0.97-$2.32 -$1.35$0.74$199.47M$254.70M
5/1/2024Q1 2024-$3.65$0.59+$4.24$1.01-$300.40M
3/6/2024Q4 2023-$0.33-$0.77 -$0.44-$0.59$247.63M$276.60M
12/11/2023Q3 2023-$0.12-$1.44 -$1.32$2.20$255.34M$270.50M
8/8/2023Q2 2023-$0.98-$1.06 -$0.08$3.03$216.17M$337.90M
5/9/2023Q1 2023-$1.67-$3.17 -$1.50-$2.69$142.85M$165.10M
2/27/2023Q4 2022$0.31-$0.31 -$0.62$1.14$298.23M$330.70M

Emergent BioSolutions Earnings - Frequently Asked Questions

Emergent BioSolutions issued an update on its FY 2024 earnings guidance on Wednesday, November, 6th. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Emergent BioSolutions (NYSE:EBS) has a recorded annual revenue of $1.09 billion.

Emergent BioSolutions (NYSE:EBS) has a recorded net income of -$760.50 million. EBS has generated -$4.10 earnings per share over the last four quarters.

Emergent BioSolutions's earnings are expected to grow from ($1.30) per share to $2.99 per share in the next year.

More Earnings Resources from MarketBeat



This page (NYSE:EBS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners